A Brooklyn federal judge on Tuesday ordered Cooley attorneys to quickly identify documents that might be turned over to Martin Shkreli, the former pharmaceutical executive charged in a fraud scheme.
Shkreli was CEO of biopharmaceutical company Retrophin Inc. until September 2014 and had used Katten Muchin Rosenman as the company’s outside counsel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
